A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide

Nature Protocols

Volumn 5, Issue 1, 2010, Pages 14-19

  Li, Changgui ^a   Jaentschke, Bozena ^b   Song, Yingli ^a   Wang, Junzhi ^a   Cyr, Terry D ^b   Van Domselaar, Gary ^c   He, Runtao ^c   Li, Xuguang ^b,d  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b HEALTH CANADA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; MEMBRANE PROTEIN; PEPTIDE; PROTEIN ANTIBODY; INFLUENZA VACCINE; VIRUS ANTIBODY;

ANALYTIC METHOD; ARTICLE; INFLUENZA VIRUS A; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN TARGETING; RELIABILITY; VIRUS CELL INTERACTION; VIRUS STRAIN; CHEMISTRY; COMPARATIVE STUDY; CONSERVED SEQUENCE; EVALUATION STUDY; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOLOGY; INFLUENZA A VIRUS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ANTIBODIES, VIRAL; CONSERVED SEQUENCE; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOBLOTTING; IMMUNODIFFUSION; INFLUENZA A VIRUS; INFLUENZA VACCINES;

INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE;

EID: 75149127241     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2009.200     Document Type: Article

References (21)

1. Skehel, J.J. & Wiley, D.C. Receptor binding and membrane fusion in virus entry: the influenza HA. Annu. Rev. Biochem. 69, 531-569 (2000).
2. Fouchier, R.A., Munster, V., Wallensten, A., Bestebroer, T.M., Herfst, S. & Smith, D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79, 2814-12222 (2005).
3. Chun, S. et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 26, 6068-6076 (2008).
4. Poland, G.A., Rottinghaus, S.T. & Jacobson, R.M. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. Vaccine 19, 2216-2220 (2001).
5. Simonsen, L., Taylor, R.J., Viboud, C., Miller, M.A. & Jackson, L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 7, 658-666 (2007).
6. Carrat, F. & Flahault, A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852-6862 (2007).
7. Bridges, C.B. et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284, 1655-1663 (2000).
8. De Filette, M. et al. Universal influenza A vaccine: optimization of M2-based constructs. Virology 337, 149-161 (2005).
9. Wood, J.M. et al. The influence of the host cell on standardisation of influenza vaccine potency. Dev. Biol. Stand. 98, 183-188 (1999).
10. World Health Organization. WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics WHO/CDS/CSR/RMD/2004.8. (World Health Organization, Department of Communicable Disease Surveillance and Response, Geneva, Switzerland, 2004).
11. Belshe, R.B. Implications of the emergence of a novel H1 influenza virus. N. Engl. J. Med. 360, 2667-2668 (2009).
12. Neumann, G., Noda, T. & Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931-939 (2009).
13. Kapteyn, J.C. et al. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine. 27, 1468-1477 (2009).
14. García-Cañas, V., Lorbetskie, B., Bertrand, D., Cyr, T.D. & Girard, M. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal. Chem. 79, 3164-3172 (2007).
15. Williams, T.L. et al. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 26, 2510-2520 (2008).
16. Luna, L.G., Williams, T.L., Pirkle, J.L. & Barr, J.R. Ultra performance liquid chromatography isotope dilution tandem mass spectrometry for the absolute quantification of proteins and peptides. Anal. Chem. 80, 2688-2693 (2008).
17. Carr, C.M., Chaudhry, C. & Kim, P.S. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc. Natl. Acad. Sci. USA 94, 14306-14313 (1997).
18. Prabhu, N. et al. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J. Virol. 83, 2553-2562 (2009).
19. Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273 (2009).
20. Ekiert, D.C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251 (2009).
21. Reimer, C.B., Baker, R.S., Van Frank, R.M., Newlin, T.E., Cline, G.B. & Anderson, N.G. Purification of large quantities of influenza virus by density gradient centrifugation. J. Virol. 1, 1207-1216 (1967).